Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Journal of Inflammation
Published in: Journal of Inflammation 1/2012

Open Access 01-12-2012 | Research

A new metabolomic assay to examine inflammation and redox pathways following LPS challenge

Authors: Jung H Suh, Robert Y Kim, Daniel S Lee

Published in: Journal of Inflammation | Issue 1/2012

Login to get access

Abstract

Background

Shifts in intracellular arginine (Arg) and sulfur amino acid (SAA) redox metabolism modulate macrophage activation, polarization and phenotype. Despite their importance in inflammation and redox regulatory pathways, comprehensive analysis of these metabolic networks was not previously possible with existing analytical methods.

Methods

The Arg/thiol redox LC-MS/MS metabolomics assay permits simultaneous assessment of amino acids and derivative products generated from Arg and SAA metabolism. Using this assay, LPS-induced changes in macrophage amino acid metabolism were monitored to identify pathway shifts during activation and their linkage to cellular redox regulation.

Results

Metabolite concentrations most significantly changed after treatment of a macrophage-like cell line (RAW) with LPS for 24 hrs were citrulline (Cit) (48-fold increase), ornithine (Orn) (8.5-fold increase), arginine (Arg) (66% decrease), and aspartic acid (Asp) (73% decrease). The ratio Cit + Orn/Arg + Asp (CO/AA) was more sensitive to LPS stimulation than other amino acid ratios commonly used to measure LPS-dependent inflammation (e.g., SAM/SAH, GSH/GSSG) and total media NOx. The CO/AA ratio was also the first ratio to change significantly after LPS treatment (4 hrs). Changes in the overall metabolomic profile over time indicated that metabolic pathways shifted from Arg catabolism to thiol oxidation.

Conclusions

Simultaneous quantification of Arg and SAA metabolic pathway shifts following LPS challenge of macrophage indicate that, in this system, the Arg-Citrulline/NO cycle and arginase pathways are the amino acid metabolic pathways most sensitive to LPS-challenge. The cellular (Cit + Orn)/(Arg + Asp) ratio, which summarizes this pathway, was more responsive to lower concentrations of LPS and responded earlier than other metabolic biomarkers of macrophage activation including GSH redox. It is suggested that the CO/AA ratio is a redox- independent early biomarker of macrophage activation. The ability to measure both the CO/AA and GSH-redox ratios simultaneously permits quantification of the relative effects of LPS challenge on macrophage inflammation and oxidative stress pathways. The use of this assay in humans is discussed, as are clinical implications.
Appendix
Available only for authorised users
Literature
1.
Libby P: Inflammatory mechanisms: The molecular basis of inflammation and disease. Nutr Rev. 2007, 65: S140-S146.CrossRefPubMed
2.
Chiurchiù V, Maccarrone M: Chronic inflammatory disorders and their redox control: From molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011, 15: 2605-2641.CrossRefPubMed
3.
Balagopal PB, de Ferranti SD, Cook S, Daniels SR, Gidding SS, Hayman LL, McCrindle BW, Mietus-Snyder ML, Steinberger J, Council on Epidemiology and Prevention: Nontraditional risk factors and biomarkers for cardiovascular disease: Mechanistic, research, and clinical considerations for youth: A scientific statement from the american heart association. Circulation. 2011, 123: 2749-2769.CrossRefPubMed
4.
Barocas DA, Motley S, Cookson MS, Chang SS, Penson DF, Dai Q, Milne G, Roberts LJ, Morrow J, Concepcion RS, Smith JA, Fowke JH: Oxidative stress measured by urine F2-isoprostane level is associated with prostate cancer. J Urol. 2011, 185: 2102-2107.PubMedCentralCrossRefPubMed
5.
Karakas M, Koenig W, Zierer A, Herder C, Rottbauer W, Baumert J, Meisinger C, Thorand B: Myeloperoxidase is associated with incident coronary heart disease independently of traditional risk factors: Results from the MONICA/KORA augsburg study. J Intern Med. 2012, 271: 43-50.CrossRefPubMed
6.
van der Zwan LP, Scheffer PG, Dekker JM, Stehouwer CD, Heine RJ, Teerlink T: Systemic inflammation is linked to low arginine and high ADMA plasma levels resulting in an unfavourable NOS substrate-to-inhibitor ratio: The hoorn study. Clin Sci (Lond). 2011, 121: 71-78.CrossRef
7.
Van Guilder GP, Hoetzer GL, Greiner JJ, Stauffer BL, Desouza CA: Influence of metabolic syndrome on biomarkers of oxidative stress and inflammation in obese adults. Obesity (Silver Spring). 2006, 14: 2127-2131.CrossRef
8.
Hamirani YS, Pandey S, Rivera JJ, Ndumele C, Budoff MJ, Blumenthal RS, Nasir K: Markers of inflammation and coronary artery calcification: A systematic review. Atherosclerosis. 2008, 201: 1-7.CrossRefPubMed
9.
Albina JE, Caldwell MD, Henry WL, Mills CD: Regulation of macrophage functions by l-arginine. J Exp Med. 1989, 169: 1021-1029.CrossRefPubMed
10.
Albina JE, Mills CD, Henry WL, Caldwell MD: Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol. 1990, 144: 3877-3880.PubMed
11.
Morris SM, Kepka-Lenhart D, Chen LC: Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. Am J Physiol. 1998, 275: E740-E747.PubMed
12.
13.
Brosnan JT, Brosnan ME: The sulfur-containing amino acids: An overview. J Nutr. 2006, 136: 1636S-1640S.PubMed
14.
Finkelstein JD: Inborn errors of sulfur-containing amino acid metabolism. J Nutr. 2006, 136: 1750S-1754S.PubMed
15.
Schafer FQ, Buettner GR: Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001, 30: 1191-1212.CrossRefPubMed
16.
17.
Wang G, Siow YL, Karmin O: Homocysteine induces monocyte chemoattractant protein-1 expression by activating NFkB in THP-1 macrophages. Am J Physiol Heart Circ Physiol. 2001, 280: H2840-H2847.PubMed
18.
Poddar R, Sivasubramanian N, DiBello PM, Robinson K, Jacobsen DW: Homocysteine induces expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human aortic endothelial cells: Implications for vascular disease. Circulation. 2001, 103: 2717-2723.CrossRefPubMed
19.
Moat SJ, Bonham JR, Powers HJ: Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease. Clin Sci (Lond). 2001, 100: 73-79.CrossRef
20.
Hofmann MA, Lalla E, Lu Y, Gleason MR, Wolf BM, Tanji N, Ferran LJ, Kohl B, Rao V, Kisiel W, Stern DM, Schmidt AM: Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest. 2001, 107: 675-683.PubMedCentralCrossRefPubMed
21.
Ozkan Y, Ozkan E, Simşek B: Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol. 2002, 82: 269-277.CrossRefPubMed
22.
Weiss N, Keller C, Hoffmann U, Loscalzo J: Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia. Vasc Med. 2002, 7: 227-239.CrossRefPubMed
23.
Dhawan SS, Eshtehardi P, McDaniel MC, Fike LV, Jones DP, Quyyumi AA, Samady H: The role of plasma aminothiols in the prediction of coronary microvascular dysfunction and plaque vulnerability. Atherosclerosis. 2011, 219: 266-272.CrossRefPubMed
24.
Zhang H, Forman HJ, Choi J: Gamma-glutamyl transpeptidase in glutathione biosynthesis. Methods Enzymol. 2005, 401: 468-483.CrossRefPubMed
25.
Lee DH, Jacobs DR: Association between serum gamma-glutamyltransferase and c-reactive protein. Atherosclerosis. 2005, 178: 327-330.CrossRefPubMed
26.
Bo S, Gambino R, Durazzo M, Guidi S, Tiozzo E, Ghione F, Gentile L, Cassader M, Pagano GF: Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: A possible implication for oxidative stress. World J Gastroenterol. 2005, 11: 7109-7117.PubMedCentralCrossRefPubMed
27.
Giral P, Jacob N, Dourmap C, Hansel B, Carrié A, Bruckert E, Girerd X, Chapman MJ: Elevated gamma-glutamyltransferase activity and perturbed thiol profile are associated with features of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008, 28: 587-593.CrossRefPubMed
28.
Jackson MJ, Allen SJ, Beaudet AL, O'Brien WE: Metabolite regulation of argininosuccinate synthetase in cultured human cells. J Biol Chem. 1988, 263: 16388-16394.PubMed
29.
Nussler AK, Billiar TR, Liu ZZ, Morris SM: Coinduction of nitric oxide synthase and argininosuccinate synthetase in a murine macrophage cell line. Implications for regulation of nitric oxide production. J Biol Chem. 1994, 269: 1257-1261.PubMed
30.
Guan X, Hoffman B, Dwivedi C, Matthees DP: A simultaneous liquid chromatography/mass spectrometric assay of glutathione, cysteine, homocysteine and their disulfides in biological samples. J Pharm Biomed Anal. 2003, 31: 251-261.CrossRefPubMed
31.
Camera E, Rinaldi M, Briganti S, Picardo M, Fanali S: Simultaneous determination of reduced and oxidized glutathione in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry. J Chromatogr B: Biomed Sci Appl. 2001, 757: 69-78.CrossRef
32.
Giustarini D, Dalle-Donne I, Colombo R, Milzani A, Rossi R: An improved HPLC measurement for GSH and GSSG in human blood. Free Radic Biol Med. 2003, 35: 1365-1372.CrossRefPubMed
33.
Zhu P, Oe T, Blair IA: Determination of cellular redox status by stable isotope dilution liquid chromatography/mass spectrometry analysis of glutathione and glutathione disulfide. Rapid Commun Mass Spectrom. 2008, 22: 432-440.CrossRefPubMed
34.
Harwood DT, Kettle AJ, Brennan S, Winterbourn CC: Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877: 3393-3399.CrossRefPubMed
35.
Brown CM, Becker JO, Wise PM, Hoofnagle AN: Simultaneous determination of 6 l-arginine metabolites in human and mouse plasma by using hydrophilic-interaction chromatography and electrospray tandem mass spectrometry. Clin Chem. 2011, 57: 701-709.PubMedCentralCrossRefPubMed
36.
Husek P: Chloroformates in gas chromatography as general purpose derivatizing agents. J Chromatogr B: Biomed Sci Appl. 1998, 717: 57-91.CrossRef
37.
Suh JH, Kim R, Yavuz B, Lee D, Lal A, Ames BN, Shigenaga MK: Clinical assay of four thiol amino acid redox couples by LC-MS/MS: Utility in thalassemia. J Chromatogr B Analyt Technol Biomed Life Sci. 2009, 877: 3418-3427.PubMedCentralCrossRefPubMed
38.
39.
Aung HT, Schroder K, Himes SR, Brion K, van Zuylen W, Trieu A, Suzuki H, Hayashizaki Y, Hume DA, Sweet MJ, Ravasi T: LPS regulates proinflammatory gene expression in macrophages by altering histone deacetylase expression. FASEB J. 2006, 20: 1315-1327.CrossRefPubMed
40.
Garg S, Vitvitsky V, Gendelman HE, Banerjee R: Monocyte differentiation, activation, and mycobacterial killing are linked to transsulfuration-dependent redox metabolism. J Biol Chem. 2006, 281: 38712-38720.CrossRefPubMed
41.
42.
Srisook K, Cha YN: Super-induction of HO-1 in macrophages stimulated with lipopolysaccharide by prior depletion of glutathione decreases iNOS expression and NO production. Nitric Oxide. 2005, 12: 70-79.CrossRefPubMed
43.
Babbar N, Murray-Stewart T, Casero RA: Inflammation and polyamine catabolism: The good, the bad and the ugly. Biochem Soc Trans. 2007, 35: 300-304.CrossRefPubMed
44.
Newsholme P: Why is l-glutamine metabolism important to cells of the immune system in health, postinjury, surgery or infection?. J Nutr. 2001, 131: 2515S-2522S. discussion 2523S-4SPubMed
45.
Tsikas D: Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res. 2005, 39: 797-815.CrossRefPubMed
46.
Nelin LD, Wang X, Zhao Q, Chicoine LG, Young TL, Hatch DM, English BK, Liu Y: MKP-1 switches arginine metabolism from nitric oxide synthase to arginase following endotoxin challenge. Am J Physiol Cell Physiol. 2007, 293: C632-C640.CrossRefPubMed
47.
MacMicking J, Xie Q, Nathan C: Nitric oxide and macrophage function. Annu Rev Immunol. 1997, 15: 323-350.CrossRefPubMed
48.
Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JM: Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003, 108: 2000-2006.CrossRefPubMed
49.
50.
Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM: M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000, 164: 6166-6173.CrossRefPubMed
51.
Bogle RG, Baydoun AR, Pearson JD, Moncada S, Mann GE: L-arginine transport is increased in macrophages generating nitric oxide. Biochem J. 1992, 284 (Pt 1): 15-18.PubMedCentralCrossRefPubMed
52.
Morris SM, Billiar TR: New insights into the regulation of inducible nitric oxide synthesis. American Journal of Physiology-Endocrinology And Metabolism. 1994, 266: E829-E839.
53.
Nicholson B, Manner CK, Kleeman J, MacLeod CL: Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem. 2001, 276: 15881-15885.CrossRefPubMed
54.
Salimuddin , Nagasaki A, Gotoh T, Isobe H, Mori M: Regulation of the genes for arginase isoforms and related enzymes in mouse macrophages by lipopolysaccharide. Am J Physiol. 1999, 277: E110-E117.PubMed
55.
Rahman I: Regulation of nuclear factor-kappa B, activator protein-1, and glutathione levels by tumor necrosis factor-alpha and dexamethasone in alveolar epithelial cells. Biochem Pharmacol. 2000, 60: 1041-1049.CrossRefPubMed
56.
Haddad JJ: Redox regulation of pro-inflammatory cytokines and ikappa B-alpha/NF-kappa B nuclear translocation and activation. Biochem Biophys Res Commun. 2002, 296: 847-856.CrossRefPubMed
57.
Nicolls MR, Haskins K, Flores SC: Oxidant stress, immune dysregulation, and vascular function in type I diabetes. Antioxid Redox Signal. 2007, 9: 879-889.CrossRefPubMed
58.
Maitra U, Singh N, Gan L, Ringwood L, Li L: IRAK-1 contributes to lipopolysaccharide-induced reactive oxygen species generation in macrophages by inducing NOX-1 transcription and rac1 activation and suppressing the expression of antioxidative enzymes. J Biol Chem. 2009, 284: 35403-35411.PubMedCentralCrossRefPubMed
59.
Matthiesen S, Lindemann D, Warnken M, Juergens UR, Racké K: Inhibition of NADPH oxidase by apocynin inhibits lipopolysaccharide (LPS) induced up-regulation of arginase in rat alveolar macrophages. Eur J Pharmacol. 2008, 579: 403-410.CrossRefPubMed
60.
Barbato JC, Catanescu O, Murray K, DiBello PM, Jacobsen DW: Targeting of metallothionein by l-homocysteine: A novel mechanism for disruption of zinc and redox homeostasis. Arterioscler Thromb Vasc Biol. 2007, 27: 49-54.PubMedCentralCrossRefPubMed
61.
Rossi R, Giustarini D, Milzani A, Dalle-Donne I: Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy humans. J Cell Mol Med. 2009, 13: 3131-3140.PubMedCentralCrossRefPubMed
62.
Lajunen T, Vikatmaa P, Bloigu A, Ikonen T, Lepäntalo M, Pussinen PJ, Saikku P, Leinonen M: Chlamydial LPS and high-sensitivity CRP levels in serum are associated with an elevated body mass index in patients with cardiovascular disease. Innate Immun. 2008, 14: 375-382.CrossRefPubMed
63.
Wiesner P, Choi SH, Almazan F, Benner C, Huang W, Diehl CJ, Gonen A, Butler S, Witztum JL, Glass CK, Miller YI: Low doses of lipopolysaccharide and minimally oxidized low-density lipoprotein cooperatively activate macrophages via nuclear factor kappa B and activator protein-1: Possible mechanism for acceleration of atherosclerosis by subclinical endotoxemia. Circ Res. 2010, 107: 56-65.PubMedCentralCrossRefPubMed
64.
Tang WH, Wang Z, Cho L, Brennan DM, Hazen SL: Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk. J Am Coll Cardiol. 2009, 53: 2061-2067.PubMedCentralCrossRefPubMed
65.
Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, Hazen SL, Vichinsky EP, Morris SM, Gladwin MT: Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA. 2005, 294: 81-90.PubMedCentralCrossRefPubMed
66.
Suh JH, Walsh WJ, McGinnis WR, Lewis A, Ames BN: Altered sulfur amino acid metabolism in immune cells of children diagnosed with autism. Am J Biochem Biotechnol. 2008, 4: 105-113.CrossRef
67.
Morris CR, Suh JH, Hagar W, Larkin S, Bland DA, Steinberg MH, Vichinsky EP, Shigenaga M, Ames B, Kuypers FA, Klings ES: Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood. 2008, 111: 402-410.PubMedCentralCrossRefPubMed
68.
Schwarzer C, Illek B, Suh JH, Remington SJ, Fischer H, Machen TE: Organelle redox of CF and CFTR-corrected airway epithelia. Free Radic Biol Med. 2007, 43: 300-316.PubMedCentralCrossRefPubMed
69.
Serikov VB, Leutenegger C, Krutilina R, Kropotov A, Pleskach N, Suh JH, Tomilin NV: Cigarette smoke extract inhibits expression of peroxiredoxin V and increases airway epithelial permeability. Inhal Toxicol. 2006, 18: 79-92.CrossRefPubMed
Metadata
Title
A new metabolomic assay to examine inflammation and redox pathways following LPS challenge
Authors
Jung H Suh
Robert Y Kim
Daniel S Lee
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2012
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-9-37

Other articles of this Issue 1/2012

Journal of Inflammation 1/2012 Go to the issue

Research

Assessment of endothelium and inflammatory response at the onset of reperfusion injury in hand surgery

Research

Inhibition of nitric oxide synthesis enhances leukocyte rolling and adhesion in human microvasculature

Research

Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis

Research

Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation

Research

Differential regulation of tissue thiol-disulfide redox status in a murine model of peritonitis

Research

18FDG PET-CT imaging detects arterial inflammation and early atherosclerosis in HIV-infected adults with cardiovascular disease risk factors

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits